Saturday, October 1, 2022
HomeInsightFunding Alert Tata 1mg raises $40 mn led by Tata Digital, becomes unicorn

[Funding alert] Tata 1mg raises $40 mn led by Tata Digital, becomes unicorn

In financing that was primarily led by Tata Digital, the e-pharmacy platform Tata 1mg raised around $40 million (Rs 319.4 crore). MPOF Mauritius Ltd, HBM Healthcare, and KWE Beteiligung are some of the additional investors in the round.

In financing that was primarily led by Tata Digital, the e-pharmacy platform Tata 1mg raised around $40 million (Rs 319.4 crore). MPOF Mauritius Ltd, HBM Healthcare, and KWE Beteiligung are some of the additional investors in the round.

Tata 1mg has reportedly been valued at $1.25 billion following a recent investment, turning it into a unicorn.

Read also – [Funding alert] Traveltech Startup Travel Buddy Raises Funding From Mumbai Angels

Founded in 2013 as Healthkartplus by Prashant Tandon, Gaurav Agarwal and Vikas Chauhan, Tata 1mg is India’s leading consumer health platform. It aspires to be the trusted health partner for all Indians and its mission is to make healthcare accessible, understandable and affordable for a billion Indians.

Tata 1mg provide accurate, authoritative & trustworthy information on medicines and help people use their medicines effectively and safely.

About Tata 1mg

It enables consumers to learn more about their medicines and also find more cost-effective substitutes. 1mg’s doctor platform aims to revolutionize how a consumer finds the right healthcare professional for his needs.

Read also – [Funding alert] TSAW Drones raises funding from Chandigarh Angel Network, Qubit Capital

It’s diagnostics service brings transparency and price-effectiveness to lab tests. 1mg is an initiative taken in the spirit of public service with a vision to empower Indian consumers and caregivers to select the most appropriate healthcare service at the best possible price. The application is available as a web portal– www.1mg.com and as mobile app across Android/ iOS.

RELATED ARTICLES
- Advertisment -

Most Popular

- Advertisment -

Also Read

- Advertisment -
Newsletter

Subscribe to our weekly newsletter and don't forget to check out the latest updates.